United States — Food and Drug Administration & Beta Bionics
2 shared events · Importance 3 · Last updated Sep 19, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The FDA's Form 483 observations and subsequent warning letter concerning Beta Bionics' quality management system and unreported complaints are central to the allegations. The agency's findings triggered the disclosure events that led to the stock decline and lawsuits.
Beta Bionics: Beta Bionics is the primary defendant in the securities class actions, facing allegations of false and misleading statements regarding its iLet Bionic Pancreas insulin pump and failure to disclose serious FDA findings. The litigation and underlying regulatory issues could materially harm its stock price, reputation, and business prospects.
Sep 05, 2026 · 68 articles
Regulatory
United States — Food and Drug Administration: The FDA granted De Novo authorization to Abbott's device, establishing new regulatory standards for continuous ketone monitoring. This action expands the regulatory framework for diabetes technology.
Beta Bionics: Beta Bionics is collaborating with Abbott to integrate its iLet automated insulin delivery system with the Libre Duo sensor, expected by end of 2026. This partnership enhances its product ecosystem.
Aug 25, 2026 · 21 articles
90
United States — Food and Drug Administration issued Warning Letter Beta BionicsBeta Bionics Securities...
90
United States — Food and Drug Administration released Warning Letter Beta BionicsBeta Bionics Securities...
85
United States — Food and Drug Administration published warning letter Beta BionicsBeta Bionics Securities...
85
United States — Food and Drug Administration released warning letter Beta BionicsBeta Bionics Securities...
75
United States — Food and Drug Administration raised issues Beta BionicsBeta Bionics Securities...
75
Beta Bionics failed to report complaints United States — Food and Drug AdministrationBeta Bionics Securities...
72
United States — Food and Drug Administration issued Form 483 Beta BionicsBeta Bionics Securities...
70
United States — Food and Drug Administration issued Form 483 Beta BionicsBeta Bionics Securities...
70
Beta Bionics received FDA warning letter United States — Food and Drug AdministrationBeta Bionics Securities...
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Beta Bionics interact across events, view sentiment trends, and discover connected entities.
Open Dashboard